Please Register for this Teleconference!  Please join IRMA, AVAC and Ian McGowan, co-principal investigator of the Microbicide Trials Network and Principal Investigator of CHARM (the Combination HIV Antiretroviral Rectal Microbicide Program) for a thoroughly CHARMing teleconference update on what is happening with this innovative program. Funded by the U.S. National Institutes of Health in 2009, CHARM is Read More >>

By Natasha Thakkar, IRMA Intern In the IRMA teleconference held on March 15th, 2012, Dr. Ian McGowan explained, the effects of 1% tenofovir gel on gene expression and regulation (click here for his slides). There were many questions on the call about gene expression and gene regulation, and because I studied Molecular and Cellular Biology at the Read More >>

Rectal Microbicide Research Update – MTN 007 and MTN 017 There are exciting new developments in the rectal microbicide field. Please join IRMA and AVAC for a FREE global teleconference Thursday, March 15, 10am eastern, featuring Drs. Ian McGowan and Ross Cranston of the Microbicide Trials Network (MTN). Ian (co-principal investigator of the MTN) will share results Read More >>

Yes, Africa Needs Rectal MicrobicidesTuesday, September 27, 2011, 10:00 EDT(click here to determine the time in your area) Please join IRMA and AVAC with our special guest Dr. Salim Abdool Karim (Slim.) Slim is a clinical infectious diseases epidemiologist whose main current research interests are in microbicides and vaccines to prevent HIV infection and implementing antiretroviral therapy Read More >>

Lube Access – A Global ChallengeMonday, August 29, 2011, 1200 EDT (click here to determine the time in your area) Please join IRMA, AVAC and partners from PSI, Johns Hopkins, and the Global Forum on MSM and HIV as we discuss lube access in the global context – highlighting the needs, gaps, and challenges, as well as Read More >>

via IRMA Enhance your advocacy skills and bone up on some of the basics. Dr. Jim Turpin of the Microbicide Research Branch at the National Institutes of Health, National Institutes of Allergy and Infectious Diseases, will explain the basic science of drug discovery – the research that happens before we move on to Phase I safety testing Read More >>

JOIN USEfficacy and Effectiveness – What is Good Enough? Who decides? Friday, December 4, 2009 7a – Los Angeles9a – Chicago, Lima10a – NYC3p – London4p – Lagos5p – Johannesburg8:30p – Delhi 2A – Sydney Join IRMA, the Global Campaign for Microbicides and the AIDS Vaccine Advocacy Coalition and our panel of distinguished speakers (below) for what Read More >>

Join IRMA, and the Global Campaign for Microbicidesfor an International Teleconference Thursday, June 11, 2009 Microbicides: The herstory of a movement If you ever wanted to know how the microbicides movement got started from two of the women who were there from the beginning, this is the teleconference for you. •How did microbicides get their name? •What Read More >>

Understanding the habits and preferences of people having anal sex: Implications for rectal microbicide developmentThursday, May 14, 2009How often do people use saliva for anal sex? What about vaginal fluid? Would people prefer a rectal microbicide that comes in a gel or a suppository? What do the answers to these questions mean for rectal microbicide development? Join Read More >>

IRMA’s next Global Teleconference Thursday, March 19, 2009 Featuring presentations by Medical Research Council’s Dr. Sheena McCormack (UK – on left), UCLA’s Dr. Peter Anton (center) and Dr. Ian McGowan, University of Pittsburgh (right). Be among the first to know about upcoming rectal microbicide trials – including rectal safety studies of tenofovir and Pro2000 – from the Read More >>